Connect with us
Spark is getting positive results with SPK-9001, an alternative drug for the treatment of a hereditary blood disorder.
Sanofi is under fire for offering anti-dengue vaccine Dengvaxia to the Philippines while it is still on clinical trial.
Last year, there was a large increase in the demand for global hematology drugs and diagnostics.